Related Experiment Video

Updated: Aug 11, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 24, 2014

Research in schizophrenia and the discontinuation of antipsychotic medications

R J Wyatt1

  • 1Neuropsychiatry Branch, NIMH Neuropsychiatric Research Hospital, Washington, DC 20032, USA.

Schizophrenia Bulletin
|January 1, 1997
PubMed

Insights

Discontinuing antipsychotic medications for schizophrenia research may pose risks. While early intervention benefits long-term outcomes, the impact of medication withdrawal on schizophrenia morbidity requires further investigation.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Clinical Research

Background:

  • Schizophrenia is a complex mental disorder with potential progressive characteristics.
  • Antipsychotic medications are a cornerstone of schizophrenia management.
  • Ethical considerations arise when withholding medication for research.

Purpose of the Study:

  • To review the potential benefits and risks of discontinuing antipsychotic medications in patients with schizophrenia for research purposes.
  • To examine evidence regarding the progressive nature of schizophrenia.
  • To highlight the need for further research on medication withdrawal effects.

Main Methods:

  • Literature review of studies on early intervention with antipsychotics.
  • Review of studies on the long-term risks of antipsychotic discontinuation in schizophrenia.
  • Synthesis of current evidence on schizophrenia progression and treatment.

Main Results:

  • Early intervention with antipsychotic medications appears to improve the long-term course of schizophrenia.
  • Limited data exists on the specific long-term morbidity associated with discontinuing antipsychotic medications.
  • The progressive nature of schizophrenia is supported by some evidence.

Conclusions:

  • Further research is essential to understand the long-term consequences of antipsychotic withdrawal in schizophrenia.
  • Informed clinical practice and research protocols require a clearer understanding of these risks.
  • Balancing research needs with patient well-being is critical.
Keywords:
Biomedical and Behavioral ResearchMental Health Therapies

More Related Videos

Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization12:00

Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization

Published on: November 19, 2014

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Related Concept Videos

Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications